PHARMAKON Trademark

Trademark Overview


On Monday, April 1, 2024, a trademark application was filed for PHARMAKON with the United States Patent and Trademark Office. The USPTO has given the PHARMAKON trademark a serial number of 98477691. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 17, 2024. The PHARMAKON trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements consisting primarily of mushrooms
pharmakon

General Information


Serial Number98477691
Word MarkPHARMAKON
Filing DateMonday, April 1, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNutritional supplements consisting primarily of mushrooms

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPortland, OR 97203

Trademark Events


Event DateEvent Description
Monday, April 1, 2024NEW APPLICATION ENTERED
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 11, 2024ASSIGNED TO EXAMINER
Thursday, October 17, 2024NON-FINAL ACTION WRITTEN
Thursday, October 17, 2024NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED